UF Researchers Receive $2.3 Million Grant to Study Survivorship in Hodgkin Lymphoma
Despite treatment advances and excellent five-year relative survival rates for people diagnosed with Hodgkin lymphoma, not all patients receive recommended treatment and survivorship care. These differences may explain the poorer survival and quality of life outcomes burdening underserved populations.